A citation-based method for searching scientific literature

William D Travis, Ulrich Costabel, David M Hansell, Talmadge E King, David A Lynch, Andrew G Nicholson, Christopher J Ryerson, Jay H Ryu, Moisés Selman, Athol U Wells, Jurgen Behr, Demosthenes Bouros, Kevin K Brown, Thomas V Colby, Harold R Collard, Carlos Robalo Cordeiro, Vincent Cottin, Bruno Crestani, Marjolein Drent, Rosalind F Dudden, Jim Egan, Kevin Flaherty, Cory Hogaboam, Yoshikazu Inoue, Takeshi Johkoh, Dong Soon Kim, Masanori Kitaichi, James Loyd, Fernando J Martinez, Jeffrey Myers, Shandra Protzko, Ganesh Raghu, Luca Richeldi, Nicola Sverzellati, Jeffrey Swigris, Dominique Valeyre. Am J Respir Crit Care Med 2013
Times Cited: 1753







List of co-cited articles
454 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
Ganesh Raghu, Harold R Collard, Jim J Egan, Fernando J Martinez, Juergen Behr, Kevin K Brown, Thomas V Colby, Jean-François Cordier, Kevin R Flaherty, Joseph A Lasky,[...]. Am J Respir Crit Care Med 2011
27

Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline.
Ganesh Raghu, Martine Remy-Jardin, Jeffrey L Myers, Luca Richeldi, Christopher J Ryerson, David J Lederer, Juergen Behr, Vincent Cottin, Sonye K Danoff, Ferran Morell,[...]. Am J Respir Crit Care Med 2018
947
26

Nintedanib in Progressive Fibrosing Interstitial Lung Diseases.
Kevin R Flaherty, Athol U Wells, Vincent Cottin, Anand Devaraj, Simon L F Walsh, Yoshikazu Inoue, Luca Richeldi, Martin Kolb, Kay Tetzlaff, Susanne Stowasser,[...]. N Engl J Med 2019
308
16

Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.
Luca Richeldi, Roland M du Bois, Ganesh Raghu, Arata Azuma, Kevin K Brown, Ulrich Costabel, Vincent Cottin, Kevin R Flaherty, David M Hansell, Yoshikazu Inoue,[...]. N Engl J Med 2014
15

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.
Talmadge E King, Williamson Z Bradford, Socorro Castro-Bernardini, Elizabeth A Fagan, Ian Glaspole, Marilyn K Glassberg, Eduard Gorina, Peter M Hopkins, David Kardatzke, Lisa Lancaster,[...]. N Engl J Med 2014
14


Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report.
Harold R Collard, Christopher J Ryerson, Tamera J Corte, Gisli Jenkins, Yasuhiro Kondoh, David J Lederer, Joyce S Lee, Toby M Maher, Athol U Wells, Katerina M Antoniou,[...]. Am J Respir Crit Care Med 2016
477
12

Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.
Oliver Distler, Kristin B Highland, Martina Gahlemann, Arata Azuma, Aryeh Fischer, Maureen D Mayes, Ganesh Raghu, Wiebke Sauter, Mannaig Girard, Margarida Alves,[...]. N Engl J Med 2019
319
11

Diagnostic criteria for idiopathic pulmonary fibrosis: a Fleischner Society White Paper.
David A Lynch, Nicola Sverzellati, William D Travis, Kevin K Brown, Thomas V Colby, Jeffrey R Galvin, Jonathan G Goldin, David M Hansell, Yoshikazu Inoue, Takeshi Johkoh,[...]. Lancet Respir Med 2018
338
10

Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes.
Taryn L Reddy, Masaki Tominaga, David M Hansell, Jan von der Thusen, Doris Rassl, Helen Parfrey, Suzy Guy, Orion Twentyman, Alexandra Rice, Toby M Maher,[...]. Eur Respir J 2012
177
9

An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features.
Aryeh Fischer, Katerina M Antoniou, Kevin K Brown, Jacques Cadranel, Tamera J Corte, Roland M du Bois, Joyce S Lee, Kevin O Leslie, David A Lynch, Eric L Matteson,[...]. Eur Respir J 2015
402
9

Usual interstitial pneumonia in rheumatoid arthritis-associated interstitial lung disease.
E J Kim, B M Elicker, F Maldonado, W R Webb, J H Ryu, J H Van Uden, J S Lee, T E King, H R Collard. Eur Respir J 2010
266
9

A multidimensional index and staging system for idiopathic pulmonary fibrosis.
Brett Ley, Christopher J Ryerson, Eric Vittinghoff, Jay H Ryu, Sara Tomassetti, Joyce S Lee, Venerino Poletti, Matteo Buccioli, Brett M Elicker, Kirk D Jones,[...]. Ann Intern Med 2012
556
9

Distinct characteristics of pleuroparenchymal fibroelastosis with usual interstitial pneumonia compared with idiopathic pulmonary fibrosis.
Tsuneyuki Oda, Takashi Ogura, Hideya Kitamura, Eri Hagiwara, Tomohisa Baba, Yasunori Enomoto, Tae Iwasawa, Koji Okudela, Tamiko Takemura, Fumikazu Sakai,[...]. Chest 2014
75
10

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
Paul W Noble, Carlo Albera, Williamson Z Bradford, Ulrich Costabel, Marilyn K Glassberg, David Kardatzke, Talmadge E King, Lisa Lancaster, Steven A Sahn, Javier Szwarcberg,[...]. Lancet 2011
8

Idiopathic pleuroparenchymal fibroelastosis: description of a novel clinicopathologic entity.
Stephen K Frankel, Carlyne D Cool, David A Lynch, Kevin K Brown. Chest 2004
166
7

Acute fibrinous and organizing pneumonia: a histological pattern of lung injury and possible variant of diffuse alveolar damage.
Mary Beth Beasley, Teri J Franks, Jeffrey R Galvin, Bernadette Gochuico, William D Travis. Arch Pathol Lab Med 2002
164
7

Standardisation of the measurement of lung volumes.
J Wanger, J L Clausen, A Coates, O F Pedersen, V Brusasco, F Burgos, R Casaburi, R Crapo, P Enright, C P M van der Grinten,[...]. Eur Respir J 2005
6

Standardisation of spirometry.
M R Miller, J Hankinson, V Brusasco, F Burgos, R Casaburi, A Coates, R Crapo, P Enright, C P M van der Grinten, P Gustafsson,[...]. Eur Respir J 2005
6

Clinical diagnosis of idiopathic pleuroparenchymal fibroelastosis: A retrospective multicenter study.
Yasunori Enomoto, Yutaro Nakamura, Yasuomi Satake, Hiromitsu Sumikawa, Takeshi Johkoh, Thomas V Colby, Hideki Yasui, Hironao Hozumi, Masato Karayama, Yuzo Suzuki,[...]. Respir Med 2017
47
12

Mycophenolate mofetil versus oral cyclophosphamide in scleroderma-related interstitial lung disease (SLS II): a randomised controlled, double-blind, parallel group trial.
Donald P Tashkin, Michael D Roth, Philip J Clements, Daniel E Furst, Dinesh Khanna, Eric C Kleerup, Jonathan Goldin, Edgar Arriola, Elizabeth R Volkmann, Suzanne Kafaja,[...]. Lancet Respir Med 2016
346
6

Clinical course and prediction of survival in idiopathic pulmonary fibrosis.
Brett Ley, Harold R Collard, Talmadge E King. Am J Respir Crit Care Med 2011
824
6

Criteria for the diagnosis of idiopathic pleuroparenchymal fibroelastosis: A proposal.
Kentaro Watanabe, Hiroshi Ishii, Fumiaki Kiyomi, Yasuhiro Terasaki, Akira Hebisawa, Yoshinori Kawabata, Takeshi Johkoh, Fumikazu Sakai, Yasuhiro Kondoh, Yoshikazu Inoue,[...]. Respir Investig 2019
24
25

Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project.
William D Travis, Gary Hunninghake, Talmadge E King, David A Lynch, Thomas V Colby, Jeffrey R Galvin, Kevin K Brown, Man Pyo Chung, Jean-François Cordier, Roland M du Bois,[...]. Am J Respir Crit Care Med 2008
309
6

Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome.
J W Song, S-B Hong, C-M Lim, Y Koh, D S Kim. Eur Respir J 2011
405
6

Pirfenidone in patients with unclassifiable progressive fibrosing interstitial lung disease: a double-blind, randomised, placebo-controlled, phase 2 trial.
Toby M Maher, Tamera J Corte, Aryeh Fischer, Michael Kreuter, David J Lederer, Maria Molina-Molina, Judit Axmann, Klaus-Uwe Kirchgaessler, Katerina Samara, Frank Gilberg,[...]. Lancet Respir Med 2020
108
6

Acute exacerbations of idiopathic pulmonary fibrosis.
Harold R Collard, Bethany B Moore, Kevin R Flaherty, Kevin K Brown, Robert J Kaner, Talmadge E King, Joseph A Lasky, James E Loyd, Imre Noth, Mitchell A Olman,[...]. Am J Respir Crit Care Med 2007
712
6

Pleuroparenchymal Fibroelastosis. A Review of Clinical, Radiological, and Pathological Characteristics.
Felix Chua, Sujal R Desai, Andrew G Nicholson, Anand Devaraj, Elisabetta Renzoni, Alexandra Rice, Athol U Wells. Ann Am Thorac Soc 2019
21
28

Clinical significance of lower-lobe interstitial lung disease on high-resolution computed tomography in patients with idiopathic pleuroparenchymal fibroelastosis.
Masato Kono, Yuiko Fujita, Kenichiro Takeda, Koichi Miyashita, Akari Tsutsumi, Takeshi Kobayashi, Yoshihiro Miki, Dai Hashimoto, Noriyuki Enomoto, Yutaro Nakamura,[...]. Respir Med 2019
9
55

Poorer Prognosis of Idiopathic Pleuroparenchymal Fibroelastosis Compared with Idiopathic Pulmonary Fibrosis in Advanced Stage.
Makoto Shioya, Mitsuo Otsuka, Gen Yamada, Yasuaki Umeda, Kimiyuki Ikeda, Hirotaka Nishikiori, Koji Kuronuma, Hirofumi Chiba, Hiroki Takahashi. Can Respir J 2018
14
35

Usual Interstitial Pneumonia Pattern in the Lower Lung Lobes as a Prognostic Factor in Idiopathic Pleuroparenchymal Fibroelastosis.
Motoyasu Kato, Shinichi Sasaki, Kana Kurokawa, Takahiro Nakamura, Tomoko Yamada, Hitoshi Sasano, Naoko Arano, Moegi Komura, Hiroaki Ihara, Osamu Nagashima,[...]. Respiration 2019
14
35

In-Hospital Mortality after Surgical Lung Biopsy for Interstitial Lung Disease in the United States. 2000 to 2011.
John P Hutchinson, Andrew W Fogarty, Tricia M McKeever, Richard B Hubbard. Am J Respir Crit Care Med 2016
180
5

A common MUC5B promoter polymorphism and pulmonary fibrosis.
Max A Seibold, Anastasia L Wise, Marcy C Speer, Mark P Steele, Kevin K Brown, James E Loyd, Tasha E Fingerlin, Weiming Zhang, Gunnar Gudmundsson, Steve D Groshong,[...]. N Engl J Med 2011
584
5

Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease.
Hyun-Kyung Lee, Dong Soon Kim, Bin Yoo, Joon Beom Seo, Jae-Yoon Rho, Thomas V Colby, Masanori Kitaichi. Chest 2005
241
5

Connective tissue disease related fibrotic lung disease: high resolution computed tomographic and pulmonary function indices as prognostic determinants.
Simon L F Walsh, Nicola Sverzellati, Anand Devaraj, Gregory J Keir, Athol U Wells, David M Hansell. Thorax 2014
100
5

Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences.
Motoki Natsuizaka, Hirofumi Chiba, Koji Kuronuma, Mitsuo Otsuka, Kazumi Kudo, Mitsuru Mori, Masashi Bando, Yukihiko Sugiyama, Hiroki Takahashi. Am J Respir Crit Care Med 2014
209
5

Fleischner Society: glossary of terms for thoracic imaging.
David M Hansell, Alexander A Bankier, Heber MacMahon, Theresa C McLoud, Nestor L Müller, Jacques Remy. Radiology 2008
5

Idiopathic Pulmonary Fibrosis.
David J Lederer, Fernando J Martinez. N Engl J Med 2018
370
5

Predicting survival across chronic interstitial lung disease: the ILD-GAP model.
Christopher J Ryerson, Eric Vittinghoff, Brett Ley, Joyce S Lee, Joshua J Mooney, Kirk D Jones, Brett M Elicker, Paul J Wolters, Laura L Koth, Talmadge E King,[...]. Chest 2014
188
5

Cyclophosphamide versus placebo in scleroderma lung disease.
Donald P Tashkin, Robert Elashoff, Philip J Clements, Jonathan Goldin, Michael D Roth, Daniel E Furst, Edgar Arriola, Richard Silver, Charlie Strange, Marcy Bolster,[...]. N Engl J Med 2006
885
5

Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis.
Ganesh Raghu, Kevin J Anstrom, Talmadge E King, Joseph A Lasky, Fernando J Martinez. N Engl J Med 2012
819
5

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline.
Ganesh Raghu, Bram Rochwerg, Yuan Zhang, Carlos A Cuello Garcia, Arata Azuma, Juergen Behr, Jan L Brozek, Harold R Collard, William Cunningham, Sakae Homma,[...]. Am J Respir Crit Care Med 2015
895
5

Distinct profile and prognostic impact of body composition changes in idiopathic pulmonary fibrosis and idiopathic pleuroparenchymal fibroelastosis.
Yuzo Suzuki, Katsuhiro Yoshimura, Yasunori Enomoto, Hideki Yasui, Hironao Hozumi, Masato Karayama, Kazuki Furuhashi, Noriyuki Enomoto, Tomoyuki Fujisawa, Yutaro Nakamura,[...]. Sci Rep 2018
22
18

Pleuroparenchymal fibroelastosis from a consecutive database: a rare disease entity?
Takeshi Nakatani, Toru Arai, Masanori Kitaichi, Masanori Akira, Kazunobu Tachibana, Chikatoshi Sugimoto, Aya Hirooka, Taisuke Tsuji, Shojiro Minomo, Seiji Hayashi,[...]. Eur Respir J 2015
40
10

Heterogeneous clinical features in patients with pulmonary fibrosis showing histology of pleuroparenchymal fibroelastosis.
Yuji Yoshida, Nobuhiko Nagata, Nobuko Tsuruta, Yasuhiko Kitasato, Kentaro Wakamatsu, Michihiro Yoshimi, Hiroshi Ishii, Takako Hirota, Naoki Hamada, Masaki Fujita,[...]. Respir Investig 2016
35
11


Pleuroparenchymal Fibroelastosis: A Review of Histopathologic Features and the Relationship Between Histologic Parameters and Survival.
Reena Khiroya, Claudio Macaluso, Maria A Montero, Athol U Wells, Felix Chua, Maria Kokosi, Toby M Maher, Anand Devaraj, Alexandra Rice, Elisabetta A Renzoni,[...]. Am J Surg Pathol 2017
29
13

Prevalence and prognosis of unclassifiable interstitial lung disease.
Christopher J Ryerson, Thomas H Urbania, Luca Richeldi, Joshua J Mooney, Joyce S Lee, Kirk D Jones, Brett M Elicker, Laura L Koth, Talmadge E King, Paul J Wolters,[...]. Eur Respir J 2013
143
4

Presentation, diagnosis and clinical course of the spectrum of progressive-fibrosing interstitial lung diseases.
Vincent Cottin, Nikhil A Hirani, David L Hotchkin, Anoop M Nambiar, Takashi Ogura, María Otaola, Dirk Skowasch, Jong Sun Park, Hataya K Poonyagariyagorn, Wim Wuyts,[...]. Eur Respir Rev 2018
96
4

Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study.
Tim Bongartz, Carlotta Nannini, Yimy F Medina-Velasquez, Sara J Achenbach, Cynthia S Crowson, Jay H Ryu, Robert Vassallo, Sherine E Gabriel, Eric L Matteson. Arthritis Rheum 2010
318
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.